Progress Against Head and Neck Cancer. 1970–1979.

Slides:

Advertisements

Similar presentations

Breast Cancer Patient Issues in Family Practice: An Interactive Session.

Advertisements

The Basics of Cancer Roswell Park Cancer Institute Grades 5-8.

Major Cancer Milestones

Progress Against Breast Cancer

Progress Against Prostate Cancer. 1970–1979 Progress Against Prostate Cancer 1970–1979 Early 1970s: Radioactive ''seeds'' proven effective for prostate.

Progress Against Lung Cancer. 1970–1979 Progress Against Lung Cancer 1970–1979 Mid-1970s: Chemotherapy combinations prove effective in small cell lung.

Progress Against Stomach Cancer. 1980–1989 Progress Against Stomach Cancer 1980– : Combination chemotherapy improves outcomes for advanced stomach.

Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970– : FDA approves doxorubicin, a vital part of combination chemotherapy.

Progress Against Bladder Cancer. Pre-1970 Progress Against Bladder Cancer Pre : Tool offers view inside bladder for first time.

Progress Against Ovarian Cancer. 1970–1979 Progress Against Ovarian Cancer 1970– : First effective combination chemotherapy regimen for ovarian.

Progress Against Testicular Cancer. 1970–1979 Progress Against Testicular Cancer 1970– : Two new drugs produce first complete remissions in advanced.

Progress Against Cervical Cancer. 1980–1989 Progress Against Cervical Cancer 1980– –1984: HPV virus is discovered to cause cervical cancer.

Progress Against Melanoma. 1970–1979 Progress Against Melanoma 1970– : Hereditary syndrome linked to increased melanoma risk.

Progress Against Leukemia. 1970–1979 Progress Against Leukemia 1970– : FDA approves doxorubicin.

Progress Against Kidney Cancer. 1970–1979 Progress Against Kidney Cancer 1970– : Removing just part of the cancerous kidney is proven safe and.

Progress Against Pancreatic Cancer. 1970–1979 Progress Against Pancreatic Cancer 1970– s: Tobacco use found to cause pancreatic cancer.

Progress Against Liver Cancer. 1970–1979 Progress Against Liver Cancer 1970– : First study finds chemotherapy effective for liver cancer.

Presenter Name(s) Issue date National Student.

Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD

Trends in incidence and mortality, England 1989 to 2010.

Advances and Emerging Therapy for Lung Cancer

Neoadjuvant Chemotherapy in Locally Advanced Squamous Cell Cancer of Head and Neck Mei Tang, MD.

National Oesophago–Gastric Cancer Audit Comparing local and national figures.

‍‍‍‍Chemotherapy in epithelial ovarian cancer. Dr.Azarm.

Surgical Management of Oropharyngeal Cancers Kerry D. Olsen, M.D. Professor, Otolaryngology Head and Neck Surgery Mayo Clinic Kerry D. Olsen, M.D. Professor,

ANDREW NG PRINCE OF WALES HOSPITAL Role of primary chemoradiation in esophageal carcinoma.

MS&E 220 Project Yuan Xiang Chew, Elizabeth A Hastings, Morris Jinhui Zhang Probabilistic Analysis of Cervical Cancer Screening and Vaccination.

Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.

Basics of Pediatric Oncology Margret E. Merino, MD Pediatric Hematology/Oncology WRAMC.

Targeting Tumors Using Endogenous Albumin

First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.

By Taylor, Lanny, and Alex. What is it?  Leukemia is an abnormal rise in the number of white blood cells. The white blood cells crowd out other blood.

By: Sydney Trecarichi, Hayley Cash and Jordan Wittig Esophageal Cancer.

Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. Eng C1, Rogers J2, Chang GJ3, You N3, Das P4, Rodriguez-Bigas.

Advanced Cancer Topics Journal Review 4/16/2009 AD.

 Identify different options of cancer therapy.  Most cancers are treated with a combination of approaches.

Insert Program or Hospital Logo Introduction Melanoma is notoriously resistant to chemotherapy. While surgical resection and adjuvant chemotherapy can.

INT Translational research in head and neck cancer: preoperative chemotherapy in oral cavity cancer based on disease molecular profiling. Paolo Bossi MSO.

End of Life Decisions by Adults with Cancer : Role of Religious Practices and Spiritual Beliefs Rudolph M. Navari, M.D., Ph.D. Assistant Dean and Director.

Eric Van Cutsem Head, Digestive Oncology, University Hospital Gasthuisberg and Professor of Internal Medicine, University of Leuven, Belgium Published.

Recent Advances in Head and Neck Cancer Robert I. Haddad, M.D., and Dong M. Shin, M.D. The NEW ENGLAND JOURNAL of MEDICINE N Engl J Med 2008;359:

1 SNDA Gemzar plus Carboplatin Treatment of Late Relapsing Ovarian Cancer.

Treatment Regimens of HER2+ Adjuvant Patients (Actuals) Source: Genentech ASCO 2005 (data release) Nov 2006 (Approval)

Heat Shock Protein 90 (HSP90) is over-expressed in p16 negative oropharyngeal squamous cell carcinoma and its inhibition in vitro potentiates the effects.

Surviving Childhood Cancer: What’s Next? Trisha Kinnard PAS 646.

Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.

Treatment of Eye Cancer in Children With Chemosurgery Pierre Gobin (1), David Abramson (2), Ira Dunkel (3) 1: Interventional Neuroradiology, Weill Cornell.

Photodynamic Therapy Lamar Institute of Technology Presented by: Amber Burks Dental Hygiene Student Danielle Chelette Dental Hygiene Student.

WARS ON CANCER,YEAR40,WHO’S WINNING 第 5 組劉俊忠蒋齡暉蕭宇彤張凱竣.

Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.

Cancer of the Head and Neck and HPV Infection Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic.

Head & Neck Ca. (Epithelial tumors) Mohamad KADRI. MD. Clinical oncology. Medical director of AlBerouni University Hospital President of Syrian Association.

By: Thien Bui and Reshma Neupane 1. Lung Cancer Lung Cancer is an uncontrolled growth of abnormal cells in one or more lungs 2 Common Types of Lung Cancer:

Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Outcome of Salvage Total Laryngectomy Following Organ.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer Slideset on: Piccart-Gebhart M, Procter M, Leyland- Jones B, et al. Trastuzumab.

MESOTHELIOMA PROGNOSIS A mesothelioma prognosis reflects how certain factors may impact your life expectancy and affect your chances of recovery. The average.

Clinical and Research Updates in Gynecologic Oncology

Omega Best Cancer Hospital - India

Metastatic Head Neck Cancer and Immunotherapy

Management of metastatic and recurrent head and neck cancer

Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial Susanne M.

Response to chemotherapy

Evolving Paradigms in Recurrent/Metastatic SCCHN

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Krop I et al. SABCS 2009;Abstract 5090.

Challenges in LA SCCHN.

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Megan Eguchi, MPh Sana karam, md, phd

Clinical response to anti-ERBB3 mAb therapy in a patient with an advanced NRG1-rearranged non–small cell lung cancer. Clinical response to anti-ERBB3 mAb.

Presentation transcript:

Progress Against Head and Neck Cancer

1970–1979

Progress Against Head and Neck Cancer 1970– : High-dose methotrexate therapy results in significant tumor shrinkage

Progress Against Head and Neck Cancer 1980–1989

Progress Against Head and Neck Cancer 1980– : Effective, less toxic two-drug therapy is introduced

Progress Against Head and Neck Cancer 1980–1989 Late 1980s–early 1990s: Combination chemoradiation first emerges

Progress Against Head and Neck Cancer 1990–1999

Progress Against Head and Neck Cancer 1990– : Better organ preservation with initial chemotherapy and radiation

Progress Against Head and Neck Cancer 1990– : Cigarette smoking and alcohol are conclusively linked to certain pharyngeal cancers

Progress Against Head and Neck Cancer 1990– : Drug approved to help with saliva production

Progress Against Head and Neck Cancer 1990– : Chemoradiation shown conclusively to benefit patients with advanced disease

Progress Against Head and Neck Cancer 2000–Present

Progress Against Head and Neck Cancer 2000–Present 2006: Treatment with new targeted drug cetuximab prolongs life

Progress Against Head and Neck Cancer 2000–Present 2007: Taxane therapy improves survival for several types of advanced head and neck cancers

Progress Against Head and Neck Cancer 2000–Present 2008: New research highlights role of HPV infection in head and neck 2008: Adding cetuximab to initial chemotherapy extends survival for advanced cancers

Progress Against Head and Neck Cancer 2000–Present 2010: HPV status and smoking affect prognosis for oropharyngeal cancer

Progress Against Head and Neck Cancer Five-Year Survival Source: National Cancer Institute

Progress Against Head and Neck Cancer Mortality Source: National Cancer Institute

Progress Against Head and Neck Cancer New Cases Source: National Cancer Institute

Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures